Senior Medical Science Liaison - Pipeline, Immunology (Mid Atlantic)
AstraZeneca
Summary
As an Immunology Pipeline MSL, you'll play a pivotal role in advancing our science to bring life-changing medicines to patients. AstraZeneca has a broad and deep pipeline of next-generation medicines in Immunology. We are seeking highly motivated and experienced individuals to support scientific dialogue, drive clinical trial engagement and foster collaborations across AstraZeneca's immunology pipeline. Your work will facilitate the running of current and future clinical programs across multiple autoimmune disease areas with a focus on rheumatology and gastroenterology.
Job description
The Immunology Pipeline MSL is a field-based professional with scientific, clinical and therapeutic area expertise, responsible for building external relationships with identified and emerging health care providers and investigators and providing scientific and clinical trial support to advance AstraZeneca's immunology pipeline. You will be working closely with global and country R&D teams, as well as medical affairs teams working on established products, to ensure strategic, cohesive account engagement and a unified external presence.
Key Responsibilities
Scientific engagement and relationship building
- Deliver enhanced scientific and medical exchange at the portfolio-level, including Cell Therapy, T cell engagers and other novel immunomodulatory monoclonal antibodies and small molecules
- Build strong, non-promotional relationships with investigators, study staff and referring HCPs at investigational sites and key scientific centers to support active and planned AZ-sponsored immunology trials
- Identify stakeholders and opportunities for engagement and collaborations with R&D and medical affairs
- Educate clinical trial sites and referring physicians on AZ's immunology portfolio and study designs to enhance understanding of objectives and drive clarity in patient identification across multiple AZ studies
Site strategy, feasibility and trial enrolment
- Map and engage disease, community, and investigator networks; identify new sites and referral pathways
- Support feasibility by assessing patient pools, standard-of-care patterns, competing trials and operational capabilities
- Obtain, synthesize and share insights with R&D to inform protocol design, site strategy, and recruitment tactics
- In collaboration with Site Management and Monitoring (SMM), proactively explore enrolment and screening barriers and support clinical trial recruitment and retention; collaborate with clinical operations to identify and facilitate resolution of investigator site issues
Requirements
- Advanced degree in a scientific discipline e.g., MD, DO, PharmD, PhD, NP, PA-C
- Minimum of 2 years field medical experience e.g. MSL or Clinical Trial Liaison role and/or minimum of 2 years clinical trial research experience within an academic, healthcare system or industry setting
- Demonstrated excellence in scientific communication across different audiences
- Proficiency in developing and maintaining medical scientific expertise
- Thorough knowledge of regulatory environment
- Ability to travel 50–70% of the time
- Must live in the territory or following cities/states: Washington D.C, North Carolina, Richmond, VA, Baltimore, MD
Benefits
- 401(k) Retirement Programs
- Paid Time Off
- Vacation & Holiday Leave
- Health Coverage
- Dental Coverage
- Vision Coverage
- Short-Term Incentive Bonuses
- Equity-Based Awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.